$2.46T
Total marketcap
$86.63B
Total volume
BTC 50.59%     ETH 15.18%
Dominance

Rapid Dose Therapeutics RDTCF Stock

0.02 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
16.1M USD
LOW - HIGH [24H]
0.02 - 0.02 USD
VOLUME [24H]
200 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.03 USD

Rapid Dose Therapeutics Price Chart

Rapid Dose Therapeutics RDTCF Financial and Trading Overview

Rapid Dose Therapeutics stock price 0.02 USD
Previous Close 0.19 USD
Open 0.04 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 0.04 - 0.04 USD
52 Week Range 0.0004 - 0.2 USD
Volume 1.5K USD
Avg. Volume 1.23K USD
Market Cap 3.83M USD
Beta (5Y Monthly) 1.126151
PE Ratio (TTM) N/A
EPS (TTM) -0.03 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

RDTCF Valuation Measures

Enterprise Value 21.67M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 5.92535
Price/Book (mrq) N/A
Enterprise Value/Revenue 33.509
Enterprise Value/EBITDA -4.456

Trading Information

Rapid Dose Therapeutics Stock Price History

Beta (5Y Monthly) 1.126151
52-Week Change -74.81%
S&P500 52-Week Change 20.43%
52 Week High 0.2 USD
52 Week Low 0.0004 USD
50-Day Moving Average 0.09 USD
200-Day Moving Average 0.03 USD

RDTCF Share Statistics

Avg. Volume (3 month) 1.23K USD
Avg. Daily Volume (10-Days) 1.28K USD
Shares Outstanding 103.57M
Float 91.64M
Short Ratio N/A
% Held by Insiders 16.36%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends February 28, 2022
Most Recent Quarter (mrq) November 30, 2022
Next Fiscal Year End February 28, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -808.042%
Gross Margin 19.10%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -76.36%
Return on Equity (ttm) -913.82%

Income Statement

Revenue (ttm) 646.75K USD
Revenue Per Share (ttm) 0.006 USD
Quarterly Revenue Growth (yoy) -33.20%
Gross Profit (ttm) 1.21M USD
EBITDA -4863749 USD
Net Income Avi to Common (ttm) -9434980 USD
Diluted EPS (ttm) -0.07
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 26.37K USD
Total Cash Per Share (mrq) 0 USD
Total Debt (mrq) 2.02M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.163
Book Value Per Share (mrq) -0.014

Cash Flow Statement

Operating Cash Flow (ttm) -874523 USD
Levered Free Cash Flow (ttm) 779.81K USD

Profile of Rapid Dose Therapeutics

Country United States
State ON
City Burlington
Address 1121 Walkers Line
ZIP L7N 2G4
Phone N/A
Website https://rapid-dose.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active ingredients into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products. It also provides product innovation, production, and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries. The company is headquartered in Burlington, Canada.

Q&A For Rapid Dose Therapeutics Stock

What is a current RDTCF stock price?

Rapid Dose Therapeutics RDTCF stock price today per share is 0.02 USD.

How to purchase Rapid Dose Therapeutics stock?

You can buy RDTCF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Rapid Dose Therapeutics?

The stock symbol or ticker of Rapid Dose Therapeutics is RDTCF.

Which industry does the Rapid Dose Therapeutics company belong to?

The Rapid Dose Therapeutics industry is Biotechnology.

How many shares does Rapid Dose Therapeutics have in circulation?

The max supply of Rapid Dose Therapeutics shares is 1.07B.

What is Rapid Dose Therapeutics Price to Earnings Ratio (PE Ratio)?

Rapid Dose Therapeutics PE Ratio is now.

What was Rapid Dose Therapeutics earnings per share over the trailing 12 months (TTM)?

Rapid Dose Therapeutics EPS is -0.03 USD over the trailing 12 months.

Which sector does the Rapid Dose Therapeutics company belong to?

The Rapid Dose Therapeutics sector is Healthcare.